Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 1 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 4 analysts offering 12 month price targets for Supernus Pharmaceuticals Inc have a median target of 39.00, with a high estimate of 43.00 and a low estimate of 36.00. The median estimate represents a 8.88% increase from the last price of 35.82.
High | 20.0% | 43.00 |
Med | 8.9% | 39.00 |
Low | 0.5% | 36.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 25, 2025.
Average growth rate | +73.11% |
Average growth rate | +13.32% |
More ▼
Revenue history & estimates in USD
Average growth rate | +3.94% |
Average growth rate | +12.51% |
More ▼